US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

36.30

+0.51001.42%

Post-market: 36.310.0100+0.03%19:57 EDT

Volume:17.89K

Turnover:646.76K

Market Cap:98.74M

PE:- -

High:36.45

Open:35.93

Low:35.75

Close:35.79

52wk High:36.84

52wk Low:23.42

Shares:2.72M

Float Shares:2.72M

Volume Ratio:0.59

T/O Rate:0.66%

Dividend:0.26

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement

Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference

Regeneron Announces Investor Conference Presentations

Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition

MT Newswires Live

Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know

US FDA Approves Regeneron's Rare Bone Disorder Drug

Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP

Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned

THOMSON REUTERS

Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva

THOMSON REUTERS

Why 2026 is Biotech's Comeback Year

Moderna's Melanoma Vaccine Trial Achieves Breakthrough, Shares Surge Over 90%

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer

Amgen Inc : Argus Research Raises Target Price to $460

THOMSON REUTERS

CSPC Innovation Subsidiary Initiates Phase Ib/II Clinical Trial for SYS6090

What This Top Biotech Fund is Buying Now

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IBBQ/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":36.3,"timestamp":1788379200000,"preClose":35.79,"halted":0,"volume":17890,"hourTrading":{"tag":"盘后","latestPrice":36.31,"preClose":36.3,"latestTime":"19:57 EDT","volume":200,"amount":7271.81,"timestamp":1788393441767,"change":0.01,"changeRate":0.000275,"amplitude":0.000275},"delay":0,"changeRate":0.014249790444258118,"floatShares":2720001,"shares":2720001,"eps":0,"marketStatus":"Closed","change":0.51,"latestTime":"09-02 16:00:00 EDT","open":35.93,"high":36.45,"low":35.7472,"amount":646762.62543,"amplitude":0.019637,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":35.79,"sharesOutstanding":2520001,"nav":35.76526,"aum":97281542.96526,"dividendRate":0.007052,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":35.79,"preClose":35.79,"latestTime":"07:00 EDT","volume":100,"amount":3579.2799999999997,"timestamp":1788346812804,"change":0,"changeRate":0,"amplitude":0.007823},"postHourTrading":{"tag":"盘后","latestPrice":36.31,"preClose":36.3,"latestTime":"19:57 EDT","volume":200,"amount":7271.81,"timestamp":1788393441767,"change":0.01,"changeRate":0.000275,"amplitude":0.000275},"volumeRatio":0.585337,"impliedVol":0.1027,"impliedVolPercentile":0.4246},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2720001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.585337,"shares":2720001,"dividePrice":0.256,"high":36.45,"amplitude":0.019637,"preClose":35.79,"low":35.7472,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":36.3,"eps":0,"divideRate":0.007052,"volume":17890,"delay":0,"ttmEps":0,"open":35.93,"prevYearClose":28.3962,"prevWeekClose":35.47,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.57,"twentyDayClose":32.93,"sixtyDayClose":28.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU1815336091.USD","IBB","IE00B19Z9Z06.USD","IDNA","LU0566484027.USD","LU0058720904.USD","LU2456880835.USD","IE00BJT1NW94.SGD","LU0061475181.USD","BIB","IE0002141913.USD","LU0417517546.SGD","BK4139","TBXU","SG9999001176.SGD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1674673691.USD","VRTX","LU0889565916.HKD","LU2462157665.USD","BK4532","LU0757428866.USD","BK4588","LU0320765992.SGD","IE00B894F039.SGD","LU1069344957.HKD","LU2089984988.USD","LU0432979614.USD","GNMX","IE00BJJMRZ35.SGD","IBBQ","LU0079474960.USD","IE00B19Z9P08.USD","LU0823416689.USD","LU0256863811.USD","IE00B4R5TH58.HKD","SPHQ","BBH","SG9999013999.USD","IE00B19Z3581.USD","VERX","BK4533","PBE","SG9999001176.USD","LU1674673428.USD","LU1035775433.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660737004","title":"Crinetics Faces Shareholder Challenges to Vertex Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660737004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660737004?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171563,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999013999.USD","IE0009355771.USD","IE00BZ9MQY76.HKD","LU0256863811.USD","LU0566484027.USD","LU1035775433.USD","BK4567","GNMX","IE00B19Z9Z06.USD","BIB","LU1815336091.USD","IDNA","LU1093756168.USD","PBE","LU1585245621.USD","LU0432979614.USD","IBBQ","VRTX","IE00BJT1NW94.SGD","IBB","IE00B4R5TH58.HKD","LU2089984988.USD","SGXZ57979304.SGD","LU2324357040.USD","LU1674673691.USD","LU2417539215.USD","SG9999001176.USD","LU2456880835.USD","SG9999001176.SGD","LU1069344957.HKD","BK4588","IE00BJJMRZ35.SGD","LU0234570918.USD","LU2362541513.USD","IE00B894F039.SGD","LU1778281490.HKD","IE00B19Z9P08.USD","LU2462157665.USD","VERX","IE00B19Z3581.USD","IE00B2B36J28.USD","BK4585","BBH","BK4139","TBXU","IE00BFTCPJ56.SGD","BK4533","LU0320765992.SGD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU0861579265.USD","LU1585245621.USD","LU1934455277.USD","IBBQ","LU1934455863.HKD","IE00BZ1G4Q59.USD","LU0122379950.USD","LU0234570918.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU2324357040.USD","TBXU","MRNA","BMED","MEDI","IE00B19Z3B42.SGD","MRNX","GNOM","LU0965509101.SGD","LU1430594728.SGD","LU0965509283.SGD","MRNY","IE00B7SZLL34.SGD","BK4139","SG9999015978.USD","LU0965508806.USD","LU0289739699.SGD","TMED","IE00BKVL7J92.USD","BK4578","LU1674673428.USD","LU0320765992.SGD","LU0889565916.HKD","BIB","IE0002270589.USD","BK4588","WDNA","LU0965509010.AUD","LU1778281490.HKD","BK4548","LGHT","BK4533","IDNA","BK4583","LU1571399168.USD","BBH","GILD","IBB","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473673","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Closed Up by 4.48% on Aug 19: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473673","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473673?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:15","pubTimestamp":1787170546,"startTime":"0","endTime":"0","summary":"• Vertex stock surged to record highs following a rival's clinical trial failure.\n• Q2 revenue beat estimates, and the company raised its full-year guidance.\n• Analysts issued bullish ratings with an average price target of $563.25.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262119122-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0432979614.USD","LU1674673428.USD","LU2237438978.USD","LU1674673691.USD","IE0002270589.USD","LU0109394709.USD","BK4533","BK4139","IE00B2B36J28.USD","LU0823416689.USD","LU2362540622.SGD","BIB","BK4585","IBBQ","PBE","IE00B894F039.SGD","GNMX","SG9999001176.USD","LU1093756325.SGD","LU2456880835.USD","LU2236285917.USD","BK4567","LU0058720904.USD","LU1585245621.USD","LU2089984988.USD","LU0061475181.USD","LU0234570918.USD","SG9999013999.USD","IE00B19Z9Z06.USD","IE00B19Z3581.USD","SGXZ57979304.SGD","LU0256863811.USD","LU2324357040.USD","IE0009355771.USD","IBB","LU0889565916.HKD","BBH","VRTX","LU2362541273.HKD","IDNA","LU0417517546.SGD","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE0002141913.USD","IE00B19Z9P08.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1778281490.HKD","BK4588","LU2417539215.USD","SG9999001176.SGD","LU1430594728.SGD","TBXU","BK4532","LU1069344957.HKD","LU2362541513.USD","LU0079474960.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU2462157665.USD","LU1093756168.USD","LU1035775433.USD","LU0320765992.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660647872","title":"Regeneron to Webcast Management Presentation at Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2660647872","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660647872?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:06","pubTimestamp":1787169960,"startTime":"0","endTime":"0","summary":"Regeneron to webcast management presentation at Wells Fargo Healthcare ConferenceRegeneron to present at the 2026 Wells Fargo Healthcare Conference on Sept. 9, 2026 at 8:45 a.m. ET.Management to appea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL2xh7x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2T93.GBP","LU0053666078.USD","LU2023250504.SGD","LU0882574055.USD","LU0058720904.USD","TBXU","IBB","LU2210150020.SGD","LU0889565916.HKD","LU0289739699.SGD","SG9999014013.SGD","BK4139","IE00BQXX3C00.GBP","LU1974910355.USD","IE00BQXX3D17.EUR","LU2237438978.USD","IBBQ","SG9999014005.SGD","LU2362540622.SGD","LU0109394709.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU0823434583.USD","IE00BN0W2V16.EUR","LU0823434740.USD","LU2362541273.HKD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","LU2095319765.USD","NDAQ","LU2468319806.SGD","REGN","LU2362541513.USD","IE00B64PRP62.GBP","LU2089984988.USD","LU0823416689.USD","BBH","IE00BN0W2W23.USD","LU2106854487.HKD","SG9999014021.USD","LU0114720955.EUR","BK4585","LU0314104364.USD","IE00BQXX3F31.USD","LU1917777945.USD","LU0320765992.SGD","SG9999014039.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473213","title":"Regeneron Announces Investor Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473213","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473213?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:05","pubTimestamp":1787169900,"startTime":"0","endTime":"0","summary":"TARRYTOWN, N.Y., Aug.  19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) will webcast management participation as follows: 2026 Wells Fargo Healthcare Conference at 8:45 a.m. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347966/0/en/regeneron-announces-investor-conference-presentations.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","TBXU","LU2468319806.SGD","BK4139","LU2089984988.USD","REGN","LU0882574055.USD","IBB","LU1974910355.USD","LU2106854487.HKD","LU0058720904.USD","LU2362541513.USD","LU2023250504.SGD","BK4585","LU0289739699.SGD","LU0889565916.HKD","BBH","BK4588","LU0114720955.EUR","LU0053666078.USD","LU2237438978.USD","LU0320765992.SGD","LU0823416689.USD","IBBQ","LU0823434740.USD","LU0823434583.USD","LU2362541273.HKD","LU2362540622.SGD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660742032","title":"Regeneron Pharmaceuticals Wins US FDA Approval For Pasatru In Ultra-Rare Musculoskeletal Condition","url":"https://stock-news.laohu8.com/highlight/detail?id=2660742032","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660742032?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:27","pubTimestamp":1787164025,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  has received approval from the US Food and Drug Administration for Pasatru to reduce new heterotopic ossification lesions and clinician-assessed flare-ups in adults with fibrodysplasia ossificans progressiva, or FOP, the drugmaker said Wednesday.FOP is an ultra-rare genetic disorder in which rogue bone formation progressively infiltrates muscles, tendons, ligaments and other connective tissues, causing loss of mobility and potentially making basic activities such as walking, eating and breathing difficult, the company said.The approval was based on phase 3 OPTIMA trial results showing Pasatru reduced new heterotopic ossification lesions by 90% at the 10 mg per kg dose and 94% at the 3 mg per kg dose versus placebo at 56 weeks, the company said.Clinician-assessed flare-ups fell 88% with the 10 mg/kg dose and 15% with the 3 mg per kg dose, the company said.Price: 840.95, Change: +30.71, Percent Change: +3.79","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2089984988.USD","LU1974910355.USD","LU2362541273.HKD","LABU","LU2237438978.USD","LU0882574055.USD","TBXU","LU0823434740.USD","LU2106854487.HKD","LU0114720955.EUR","LU0320765992.SGD","BK4139","LU0889565916.HKD","IBB","LU0109394709.USD","LU2468319806.SGD","IBBQ","BK4585","LU0058720904.USD","LU1917777945.USD","LU0823434583.USD","LU2362540622.SGD","LU0823416689.USD","BK4588","LU2362541513.USD","LU0053666078.USD","REGN","LU2023250504.SGD","LU0289739699.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660420810","title":"Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2660420810","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660420810?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:15","pubTimestamp":1787163346,"startTime":"0","endTime":"0","summary":"• Argus raised Amgen's price target and reiterated a Buy rating.\n• Second-quarter financial performance exceeded Wall Street revenue and earnings expectations.\n• Technical indicators show a MACD buy signal and RSI buy condition.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262118745-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","04332","LU2468319806.SGD","PJP","TBXU","LU1983299246.USD","BK4588","IE00BJT1NW94.SGD","PBE","BK4533","LU1061106388.HKD","LU2242652126.USD","AMGN","BK4599","SG9999001440.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0889565916.HKD","BIB","BK4566","IE00B2B36J28.USD","LU0868494617.USD","LU2242646821.SGD","IE0009355771.USD","IBB","IE0002141913.USD","LU1571399168.USD","IBBQ","BBH","LU0122379950.USD","BK4581","LU1057294990.SGD","BK4139","LU0058720904.USD","LU1023059063.AUD","LU2089984988.USD","LU0289739699.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660272694","title":"US FDA Approves Regeneron's Rare Bone Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2660272694","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660272694?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162562,"startTime":"0","endTime":"0","summary":"US FDA approves Regeneron's rare bone disorder drugAug 19-The U.S. Food and Drug Administration on Wednesday approved Regeneron'sREGN.Oexperimental treatment fora rare genetic disorder after the drug significantly reduced abnormal bone formation in certain soft tissues.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G1JN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU2106854487.HKD","LU2362541273.HKD","LU0320765992.SGD","LU0289739699.SGD","LU0114720955.EUR","LU0053666078.USD","LU0058720904.USD","LU2468319806.SGD","REGN","LU0823434740.USD","LU1917777945.USD","LU2023250504.SGD","LU0823416689.USD","IBB","LU0109394709.USD","BK4139","LU0889565916.HKD","LU1974910355.USD","LU2362541513.USD","LU2362540622.SGD","LU2089984988.USD","BK4585","BBH","TBXU","LU0823434583.USD","LU0882574055.USD","LU2237438978.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660264427","title":"Regeneron Says FDA Approves Pasatru for Adults with Rare Bone Disorder FOP","url":"https://stock-news.laohu8.com/highlight/detail?id=2660264427","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660264427?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:02","pubTimestamp":1787162537,"startTime":"0","endTime":"0","summary":"Regeneron says FDA approves Pasatru for adults with rare bone disorder FOPRegeneron won FDA clearance for Pasatru (garetosmab-grts) to curb new HO lesions, clinician-assessed flare-ups in adults with ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDLKHCsC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0109394709.USD","LU0823416689.USD","LU1917777945.USD","LU2023250504.SGD","LU1974910355.USD","LU2468319806.SGD","BK4139","LU0823434583.USD","REGN","LU2362541513.USD","TBXU","BK4588","LU2089984988.USD","LU0058720904.USD","IBBQ","LU2362541273.HKD","BK4585","LU0053666078.USD","LU2237438978.USD","LU0889565916.HKD","LU0320765992.SGD","LU0823434740.USD","LU2106854487.HKD","LU2362540622.SGD","IBB","LU0289739699.SGD","BBH","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427109","title":"Regeneron Pharmaceuticals, - Pasatru Under Review by European Medicines Agency; Global Submissions Planned","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427109?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0109394709.USD","TBXU","LU1917777945.USD","LU2089984988.USD","LU2362540622.SGD","LU0114720955.EUR","LU1974910355.USD","LU0320765992.SGD","BBH","LU0882574055.USD","LU2237438978.USD","BK4588","LU0058720904.USD","LU0823434740.USD","LU2362541273.HKD","LU2106854487.HKD","BK4585","LU0289739699.SGD","IBBQ","REGN","LU0823434583.USD","LU0053666078.USD","LU0889565916.HKD","LU2362541513.USD","LU2468319806.SGD","LU2023250504.SGD","BK4139","IBB","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427103","title":"Regeneron Pharmaceuticals, - FDA Approves Pasatru (Garetosmab-Grts) for Adults with Fibrodysplasia Ossificans Progressiva","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427103?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:58","pubTimestamp":1787162335,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G1BJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2468319806.SGD","LU2237438978.USD","LU2362541513.USD","TBXU","LU2362541273.HKD","LU2089984988.USD","LU0058720904.USD","LU0289739699.SGD","LU2106854487.HKD","LU0320765992.SGD","BK4585","LU0823434740.USD","LU1974910355.USD","IBB","BBH","BK4139","LU0114720955.EUR","LU2362540622.SGD","LU0889565916.HKD","LU2023250504.SGD","LU0823434583.USD","LU1917777945.USD","LU0823416689.USD","BK4588","REGN","LU0053666078.USD","LU0882574055.USD","IBBQ","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421798","title":"Why 2026 is Biotech's Comeback Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421798","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421798?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:16","pubTimestamp":1787152560,"startTime":"0","endTime":"0","summary":"This article was originally published on April 1, 2026. It has been updated to reflect recent developments.After a rough past few years, the biotech sector looks to be turning a corner. Major pharmace","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ99366536.SGD","LU2237443622.USD","IE00B775H168.HKD","SGXZ81514606.USD","BK4516","HRTS","IE0001KFT4U8.USD","LU1093756325.SGD","LU2746668974.SGD","IE00BWXC8680.SGD","IE00BFTCPJ56.SGD","LU0820562030.AUD","IE0002141913.USD","AGNG","LU0882574139.USD","LU2108987350.USD","IE00BZ1G4Q59.USD","LU0471298694.HKD","SG9999001176.SGD","04332","SG9999017495.SGD","LU2471134952.CNY","LU0203201768.USD","LU1979441026.SGD","BK4581","IE00BJJMRX11.SGD","LU0432979614.USD","LU2028103732.USD","LU2111349929.HKD","LU2357305700.SGD","LU2750360997.AUD","SG9999015945.SGD","GB00BDT5M118.USD","LU1064131342.USD","IBB","LU0109391861.USD","LU0158827948.USD","LU0964807845.USD","LU1988902786.USD","LU1548497426.USD","LU2211815571.USD","NVOX","IE0005OL40V9.USD","LU1280957306.USD","LU2237438978.USD","SG9999018865.SGD","LU1057294990.SGD","IYH","LU0210536198.USD","ILDR","LU1720051017.SGD","LU1061106388.HKD","PJP","SG9999013999.USD","LU2112291526.USD","LU2552382058.USD","LU0122379950.USD","LU0198837287.USD","NVOH","IE00B7KXQ091.USD","LU0158827781.USD","LU2237443895.HKD","SG9999014898.SGD","IE00B1BXHZ80.USD","LU2750360641.GBP","LU0320765992.SGD","LU1974910355.USD","LU0234572021.USD","ELIL","LLYZ","LU0106261372.USD","TRUH","LU1232071149.USD","LLII","IHE","LU2023250330.USD","LU1145028129.USD","IDNA","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0354030511.USD","LU2089984988.USD","BK4566","LU2237443978.SGD","LU2756315664.SGD","LU2491050071.SGD","LU0353189763.USD","IE00BFSS7M15.SGD","LU2471134796.USD","FTXH","LU1691799644.USD","AMGN","LU2417539215.USD","GNOM","OZEM","LU0385154629.USD","LU0006306889.USD","MRNY","LU0786609619.USD","TBXU","LU2896262040.SGD","LU2106854487.HKD","SG9999015952.SGD","LU1551013342.USD","LU1023059063.AUD","LU1868837300.USD","LU1917777945.USD","LU0266013472.USD","BBH","LU2237443382.USD","IE00BJJMRY28.SGD","LU2242652126.USD","IXJ","LU0683600562.USD","LU0456855351.SGD","LU0466842654.USD","LU1323610961.USD","MRNX","LU1291159041.SGD","LU1804176565.USD","LU2756315318.SGD","MEDX","PPH","SG9999014880.SGD","LU2168564149.EUR","BK4599","CURE","LU1035775433.USD","LU2168564495.EUR","LU2471134879.HKD","PBE","MRNA","LU0225283273.USD","BK4532","LU2456880835.USD","LU2361045086.USD","LU2023250504.SGD","SGXZ31699556.SGD","XLV","BK4139","LU2491050154.USD","BK4588","LU1629891620.HKD","LU0823434583.USD","LGHT","LU0471298777.SGD","LU0672654240.SGD","BK4551","LU2063271972.USD","LU2461242641.AUD","LU0097036916.USD","LU0320765059.SGD","LU0114720955.EUR","LU2360106947.USD","IE0004445239.USD","LU1983299246.USD","SG9999001176.USD","IE00BJLML261.HKD","LU2264538146.SGD","LU0096364046.USD","BK4007","LU0889565916.HKD","IE00BK4W5L77.USD","SGXZ57979304.SGD","LU0689472784.USD","LU2462591350.SGD","LU0061475181.USD","SG9999014914.USD","LU2324357040.USD","LU2168564222.USD","LU1069344957.HKD","SG9999015986.USD","LU2746668461.USD","BK4585","LLYX","JDOC","LU1623119135.USD","LU1814569148.SGD","LU2213496289.HKD","LU0943347566.SGD","LU0109394709.USD","LU0882574055.USD","GDOC","MHIP","LU2471134523.USD","LU0133085943.USD","LU0787776722.HKD","LU1366192091.USD","IE00BKVL7J92.USD","LU2265009873.SGD","LU0345770993.USD","LU2361044865.SGD","LU0154236417.USD","FHLC","LU0256863811.USD","LU1267930730.SGD","BIB","WDNA","LU1093756168.USD","LU1989771016.USD","IE00BN29S564.USD","TMED","LU0323591593.USD","ELIS","LU0353189680.USD","LU2462157665.USD","LU0094547139.USD","SG9999001440.SGD","LU2089283258.USD","BK4534","IE00B2B36J28.USD","LU2023251221.USD","LU2237443465.HKD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","SG9999018857.SGD","LU1868837136.USD","LU2236285917.USD","BK4533","BK4568","LU0640476718.USD","LU1551013425.SGD","LU2468319806.SGD","LU2602419157.SGD","LU2237443549.SGD","MEDI","LU0079474960.USD","LU0820561909.HKD","IE00BKDWB100.SGD","LU0345770308.USD","LU2552382215.SGD","NVO","LU0354030438.USD","LU2361044949.HKD","THNR","LU2242646821.SGD","IE00BK4W5M84.HKD","LU2552382132.HKD","VHT","SGXZ51526630.SGD","LU0238689110.USD","IE00BKPKM429.USD","LU1868836914.USD","LU0256863902.USD","LU2168564065.EUR","LU1868836757.USD","LU0823416689.USD","LU0203202063.USD","LU2271345857.HKD","LU0823434740.USD","CANC","IE00B4JS1V06.HKD","LU0174119429.USD","LU2087625088.SGD","RXL","LU1720051108.HKD","SG9999014906.USD","BK4548","IE0004445015.USD","LLY","LU0316494557.USD","LU0708995401.HKD","LU1868836591.USD","LU0868494617.USD","IBBQ","LU2089284900.SGD","LU2491049909.HKD","LU2168563687.JPY","SG9999015978.USD","LU1712237335.SGD","LU0820561818.USD","IE00B1XK9C88.USD","LU1127390331.HKD","LU1571399168.USD","LU0058720904.USD","IE0009355771.USD","LU0417517546.SGD","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100645668","title":"Moderna's Melanoma Vaccine Trial Achieves Breakthrough, Shares Surge Over 90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100645668","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100645668?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:50","pubTimestamp":1787147459,"startTime":"0","endTime":"0","summary":"American vaccine manufacturer Moderna has seen its stock price soar by more than 90% following the announcement of successful clinical trial results for an investigational skin cancer vaccine. On...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","159646","PSYK","IBBJ","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426691","title":"Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426691","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426691?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:45","pubTimestamp":1787147100,"startTime":"0","endTime":"0","summary":"DJ Merck, Amgen Share Gains Contribute To Dow's 161-Point ClimbThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Merck and Amgen are posting positive gains Wednesday morning, lifting the Dow Jones Industrial Average into positive territory.Shares of Merck  and Amgen  have contributed to the blue-chip gauge's intraday rally, as the Dow  was most recently trading 161 points higher .Merck's shares have climbed $12.37  while those of Amgen are up $13.30 , combining for an approximately 153-point bump for the Dow.Other components contributing significantly to the gain include Sherwin-Williams Co. , Home Depot , and Salesforce .A $1 move in any one of the 30 components of the benchmark results in a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 19, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2023250504.SGD","LU2125154778.USD","FDN","PPH","LU1929549753.HKD","IE00B1BXHZ80.USD","LU1116320901.HKD","IE00BJJMRZ35.SGD","MYMmain","IE00BFTCPJ56.SGD","IHE","IE0009355771.USD","LU2491050071.SGD","DIA","PBE","DJX","LU0477156953.USD","IE00B4R5TH58.HKD","LU0265550946.USD","LU1061106388.HKD","SG9999015358.SGD","LU0211331839.USD","LU1035773651.USD","LU2125909593.SGD","LU0109394709.USD","LU0868494708.USD","IYH","LU2089984988.USD","LU1066051225.USD","LU1201861249.SGD","PJP","LU1571399168.USD","LU2357627491.SGD","HRTS","LU0889565916.HKD","BK4007","LU2361044949.HKD","LU0965509283.SGD","LU0058720904.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU1941712348.USD","BK4581","LU1093756325.SGD","IE00BN8TJ469.HKD","AMGN","LU1162221912.USD","LU1989772840.SGD","IE000M9KFDE8.USD","LU1057294990.SGD","VHT","TOPT","LU0859254822.USD",".DJI","DDM","LU0098860793.USD","LU0320765489.SGD","LU1066051498.USD","LU1934455863.HKD","MRK","SGXZ57979304.SGD","SG9999015341.SGD","LU0985320562.USD","LU0868494617.USD","IE00BLSP4239.USD","LU1093756168.USD","LU1699723380.USD","LU0320765992.SGD","RXL","DOG","LU2491050154.USD","SDY","LU1983299246.USD","BMED","FDVV","LU1917777945.USD","LU0861579265.USD","LU1430594728.SGD","LU2242646821.SGD","SG9999002224.SGD","LU0942090050.USD","DJIA","LU0432979614.USD","LU2361044865.SGD","BK4533","LU0965509010.AUD","LU0648001328.SGD","GRNY","LU0124676726.USD","LU1989771016.USD","IE00B2B36J28.USD","LU0965508806.USD","IBB","LU2324357040.USD","BK4550","IXJ","LU0130102774.USD","GDOC","LU0130517989.USD","LU1934455194.USD","LU1037948541.HKD","IE0002141913.USD","DGRW","SDOW","LU2023250843.SGD","DXD","VYM","LU2361045086.USD","SG9999002232.USD","SCHG","SG9999014559.SGD","LU0070302665.USD","SG9999014575.USD","LU0208291251.USD","BK4516","BK4585","BIB","LU0234572021.USD","MGK","VYMI","BK4599","FHLC","IE00BBT3K403.USD","LU1585245621.USD","LU0689626769.HKD","BK4588","SG9999001176.SGD","LU2491049909.HKD","UDOW","LU0122379950.USD","SCHD","XLI","IBBQ","IE00BLSP4452.SGD","LU2106854487.HKD","DGRO","LU2360032135.SGD","LU0203347892.USD","FTXH","LU2461242641.AUD","LU2125154935.USD","LU2125909247.SGD","LU2468319806.SGD","LU2112291526.USD","PAWZ","LU0006306889.USD","LU0266013472.USD","DVY","LU1989772923.USD","LU1116320737.USD","JDOC","LU1066051811.HKD","LU0265550359.USD","LU1941712264.USD","LU0289739699.SGD","BK4534","LU2433249047.HKD","LU2242652126.USD","LU1069347547.HKD","LU1934455277.USD","BK4559","BK4139","VUG","YMAX","BK4566","LU0320765646.SGD","LU1923622614.USD","LU1066053197.SGD","SG9999001440.SGD","SG9999013999.USD","XLV","BBH","LU0965509101.SGD","LU1023059063.AUD","LU0980610538.SGD","TBXU","LU0203345920.USD","SG9999014542.SGD","LU0238689110.USD","IE00BSNM7G36.USD","04332","LU1037948897.HKD","LU1974910355.USD","LU0106261372.USD","TRUH","LU1291159041.SGD","SG9999014567.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178000037","title":"Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1178000037","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178000037?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:08","pubTimestamp":1787141307,"startTime":"0","endTime":"0","summary":"On August 19, Hengrui Pharma (01276) released its 2026 semi-annual report. During the reporting period, the company achieved operating revenue of RMB 15.456 billion, with product sales revenue of RMB...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","LU2148510915.USD","LU1255011170.USD","LU1064130708.USD","BK1161","LU2097828714.EUR","LU2580892862.HKD","06978","LU0405327494.USD","LU1997245094.SGD","LU1655091616.SGD","BK0183","LU1023057109.AUD","LU0405327148.USD","LU2097828557.USD","LU1997244956.HKD","159992","LU1969619763.USD","BK1191","IBBQ","LU2097828805.USD","LU2488822045.USD","LU1781817850.SGD","600276","LU2328871848.SGD","MEDX","LU2543165471.USD","LU1580142542.USD","LU2495084118.USD","LNGR","LU0359201885.HKD","BK0012","LU1064131003.USD","01276","BK0060","LU1997245177.USD","BK0028","BK0188","BK1574","LU2580892789.USD","LU2097828474.EUR","LU0359202008.SGD","LU1820825898.SGD","LU2097828631.EUR","LU1328615791.USD","LU0359201612.USD","LU1146622755.USD","LU2289578879.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660142854","title":"BetterLife Pharma Names Mahan Chehrenama Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142854","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142854?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:04","pubTimestamp":1787141066,"startTime":"0","endTime":"0","summary":"BetterLife Pharma names Mahan Chehrenama chief medical officerBetterLife Pharma named Mahan Chehrenama as chief medical officer to lead clinical development of BETR-001.BETR-001 is advancing toward an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL40h7WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2468319806.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IBBQ","LU2242652126.USD","BK4585","IE00BJJMRZ35.SGD","PJP","TBXU","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0122379950.USD","IE0009355771.USD","BK4533","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0868494617.USD","LU0320765992.SGD","BK4588","IE0002141913.USD","BK4566","LU1571399168.USD","BK4599","LU1023059063.AUD","LU2242646821.SGD","PBE","LU1061106388.HKD","LU0289739699.SGD","BK4534","IBB","LU0889565916.HKD","SG9999001440.SGD","AMGN","BIB","LU1983299246.USD","BK4139","LU2089984988.USD","BBH","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660344705","title":"Amgen Inc : Argus Research Raises Target Price to $460","url":"https://stock-news.laohu8.com/highlight/detail?id=2660344705","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660344705?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:25","pubTimestamp":1787138742,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0VV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1061106388.HKD","LU2242652126.USD","IBBQ","IBB","LU1023059063.AUD","LU2089984988.USD","LU2112291526.USD","BK4581","BIB","IE00BFTCPJ56.SGD","IE0002141913.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","SG9999001440.SGD","LU2468319806.SGD","AMGN","LU0058720904.USD","PBE","LU1057294990.SGD","PJP","BK4588","BK4533","IE00BJT1NW94.SGD","LU0122379950.USD","LU2242646821.SGD","IE00B4R5TH58.HKD","LU0868494617.USD","LU1983299246.USD","LU0889565916.HKD","BK4534","TBXU","LU1571399168.USD","BK4599","LU0320765992.SGD","LU0289739699.SGD","BK4585","BBH","IE00B2B36J28.USD","BK4566","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169059614","title":"CSPC Innovation Subsidiary Initiates Phase Ib/II Clinical Trial for SYS6090","url":"https://stock-news.laohu8.com/highlight/detail?id=1169059614","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169059614?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:04","pubTimestamp":1787126666,"startTime":"0","endTime":"0","summary":"Cspc Innovation Pharmaceutical Co., Ltd. (300765.SZ) has announced that its controlling subsidiary, CSPC Megalith Biopharmaceutical Co., Ltd., recently kicked off a Phase Ib/II clinical trial...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","MDTX","PSYK","BK0226","IBBJ","BMED","300765"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660417405","title":"What This Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2660417405","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660417405?lang=en_us&edition=fundamental","pubTime":"2026-08-19 14:30","pubTimestamp":1787121000,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BDGV0183.EUR","LU0266013472.USD","LU2461242641.AUD","RXL","LU1934455194.USD","LU1323610961.USD","IE0002270589.USD","LU0256863902.USD","LU2023251221.USD","BK4532","AGNG","LU2505996681.GBP","GNMX","SG9999013999.USD","LU0882574139.USD","OZEM","LU0354030511.USD","LU0868494617.USD","LU1934455863.HKD","LU0553294199.USD","SG9999001176.SGD","LU1145028129.USD","TBXU","LU2361044865.SGD","LU0238689110.USD","SGXZ51526630.SGD","LU2347655073.USD","LU2237443549.SGD","VHT","IE00B894F039.SGD","BK4139","LU2360106947.USD","IE000MB6IJN5.SGD","LLY","LU1430594728.SGD","IE00B2B36J28.USD","LU0708994859.HKD","LU2265009873.SGD","LU0029864427.USD","LU0345770308.USD","LU0353189680.USD","SGXZ81514606.USD","LU0203347892.USD","LU2430703251.USD","LU2468319806.SGD","LU2087625088.SGD","LU0289961442.SGD","LU0210528500.USD","LU1814569148.SGD","LU0225283273.USD","IE00BK4W5L77.USD","LU2125909593.SGD","SG9999002232.USD","SG9999014898.SGD","LU2433249047.HKD","LU1894683348.USD","LU2357627491.SGD","IE00BJJMRY28.SGD","LU1979441026.SGD","LU0114720955.EUR","LU0162691827.USD","SG9999002224.SGD","LU2357305700.SGD","LU0820561909.HKD","LU1868836591.USD","LU0310799852.SGD","LU1720051108.HKD","LU2430703095.HKD","LU2347655156.SGD","IHE","LU2242652126.USD","LU2129689431.USD","LU2168564495.EUR","LU1228905540.USD","LU2491049909.HKD","LU2491050154.USD","MEDX","LU0385154629.USD","LU1093756168.USD","LU1291159041.SGD","LU2362541273.HKD","IE00BJJMRX11.SGD","LU2592432038.USD","LU2237443622.USD","SG9999015945.SGD","BK4566","IE0000B7K699.USD","IE00B42XCP33.USD","XDNA","LU0122379950.USD","LU0426417589.USD","LU0861579265.USD","IE0005OL40V9.USD","FHLC","LU0395794307.EUR","IE00BN0W2V16.EUR","LU2756315318.SGD","LU0323591593.USD","LU0426412945.USD","LU1496350171.SGD","IE00BFXG1179.USD","LU1551013425.SGD","LU0174119429.USD","IE000M9KFDE8.USD","LU2471134952.CNY","GILD","LU2108987350.USD","LU0109394709.USD","LU2237443382.USD","LU1162221912.USD","LU1548497426.USD","LU1868836757.USD","IE00BJLML261.HKD","BK4516","LU0072461881.USD","SG9999015952.SGD","IE00B19Z9P08.USD","LU1244550577.SGD","LU1280957306.USD","BK4550","IE0001KFT4U8.USD","HRTS","IE00BN0W2W23.USD","MHIP","ELIL","LU0310800379.SGD","SG9999015978.USD","SG9999015986.USD","LU1232071149.USD","LU0061475181.USD","LU1244550221.USD","LLYX","BIB","LU1894683264.USD","IYH","LU0466842654.USD","IE00BN0W2T93.GBP","LU2362540622.SGD","LU2403377893.USD","LU0234572021.USD","LU1674673428.USD","LU2063271972.USD","LU2237443978.SGD","LU0345769128.USD","LU1032466523.USD","LU1551013342.USD","LU1267930490.SGD","IDNA","SG9999014906.USD","LU1032955483.USD","GLAM","LU0154245673.USD","LU0203345920.USD","LU2237443895.HKD","SGXZ80539844.SGD","BBH","IE0002141913.USD","LU0786609619.USD","LU0109391861.USD","LU1267930730.SGD","LU0965509010.AUD","LU0672654240.SGD","LU1093756325.SGD","IE00B19Z3581.USD","BK4559","BK4567","TRUH","LU2456880835.USD","LU2896262040.SGD","JAZZ","LU0316494557.USD","IE0004445015.USD","BK4583","LU1670628061.USD","SGXZ99366536.SGD","IE00B3PB1722.GBP","LU0882574055.USD","LU0069063385.USD","IE00B775H168.HKD","IE00BFTCPJ56.SGD","LU2168564149.EUR","CURE","LU1868837136.USD","LU0211327993.USD","LU2430703178.SGD","SG9999017495.SGD","LU1228905037.USD","BK4568","LU0070217475.USD","LU2106854487.HKD","IE00B7SZLL34.SGD","LU2362541513.USD","LU2271345857.HKD","LU2237443465.HKD","BK4588","04332","LU0256863811.USD","LU1917777945.USD","BK4592","LU1043141123.HKD","LU0211328371.USD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU0640476718.USD","IE000F7OJYX1.SGD","LU0889566641.SGD","BK4578","SG9999018857.SGD","IBB","IE00BLSP4239.USD","LU2552382215.SGD","SG9999018865.SGD","VRTX","LU0859254822.USD","LU2236285917.USD","LU1983299246.USD","LU2242646821.SGD","LU0345770993.USD","IE00BK4W5M84.HKD","LU1069344957.HKD","LU1623119135.USD","LU1267930573.SGD","LU1074936037.SGD","SG9999014914.USD","IE00BKDWB100.SGD","IE0009355771.USD","ELIS","JNJ","LU0942090050.USD","LU2129689605.HKD","LU0661504455.SGD","IE00B1BXHZ80.USD","LU2213496289.HKD","LU0203202063.USD","IE00BFSS8Q28.SGD","LU2552382132.HKD","LU0820562030.AUD","LU1043141396.HKD","LU0472753341.HKD","LU0320765646.SGD","LU2602419157.SGD","LU1804176565.USD","LU1221951046.USD","SGXZ31699556.SGD","IE000BZT7R73.USD","LU2087621335.USD","IXJ","SGXZ57979304.SGD","BMED","LU1720051017.SGD","LU0289739343.SGD","LU1732799900.SGD","LU2361045086.USD","LU1244550494.USD","LU0943347566.SGD","LLII","LU1066053197.SGD","IE000SO60NU8.SGD","SG9999003800.SGD","LU0096364046.USD","LU2750360641.GBP","LU1261432733.SGD","LU1989772840.SGD","LU0158827948.USD","SG9999014880.SGD","MEDI","IE00B1XK9C88.USD","LU0820561818.USD","LU0456855351.SGD","LU0154245756.USD","LU1929549753.HKD","IE00BWXC8680.SGD","LU1496350502.SGD","LU1585245621.USD","LU1934455277.USD","LU0708995401.HKD","IE00BZ9MQY76.HKD","BK4504","LU0545039389.USD","IBBQ","LU0289739699.SGD","LU1974910355.USD","SG9999001440.SGD","LU0511384066.AUD","LU1718418525.SGD","IE00BBT3K403.USD","LU2133065610.SGD","SG9999011175.SGD","LU0545562505.USD","LU0683600562.USD","LU2264538146.SGD","LU0353189763.USD","LU1732800096.USD","BK4534","IE00BJT1NW94.SGD","THNR","IE0034235303.USD","LU2750360997.AUD","LU2089984988.USD","LU0949170772.SGD","LU2487616109.SGD","LU0471298777.SGD","LU2023250330.USD","IE000WAW04H5.SGD","LU2417539215.USD","LU1506573853.SGD","LU1035775433.USD","LU1037948541.HKD","LU0417517546.SGD","LU2168564222.USD","LU1066051811.HKD","LU1023059063.AUD","BK4533","LU0823434740.USD","IE00B3T34201.USD","LU0106261372.USD","FTXH","LU2491050071.SGD","LU1674673691.USD","LU0471298694.HKD","AMGN","LU0320765992.SGD","LU0689472784.USD","LU2471134523.USD","LU0098860793.USD","BK4007","IE00BN29S564.USD","IE00B4R5TH58.HKD","LU2237438978.USD","IE00BJJMRZ35.SGD","LU0203201768.USD","LU0823416689.USD","LU0345769631.USD","TMED","LU0868494708.USD","LU0964807845.USD","IE00B4JS1V06.HKD","LU2211815571.USD","LU2168563687.JPY","LU0124676726.USD","LU2462591350.SGD","LU2168564065.EUR","LU0965509101.SGD","LU0354030438.USD","LU0053666078.USD","LU1670627923.USD","LU0170899867.USD","LU1923622614.USD","WDNA","LU1196500208.SGD","LU2089284900.SGD","PPH","LU1839511570.USD","IE00BKPKM429.USD","IE00BKVL7J92.USD","LU2089283258.USD","LU2361044949.HKD","IE00B19Z3B42.SGD","LU2471134879.HKD","LU0985320562.USD","LU1935042991.SGD","LU0795875086.SGD","LU0158827781.USD","LU0689626769.HKD","LU1121112475.USD","IE00BFSS7M15.SGD","LU0097036916.USD","LU2028103732.USD","LU0058720904.USD","LLYZ","LU0787776722.HKD","LU2746668974.SGD","LU0006306889.USD","LU1221951129.SGD","LU0965508806.USD","BK4581","LU0738911758.USD","LU2111349929.HKD","REGN","LU0726765562.USD","LU1989772923.USD","IE00B7KXQ091.USD","LU1003077747.HKD","LU0889565916.HKD","LU0210536198.USD","LU1066051225.USD","BK4599","LU1059921491.USD","JDOC","LU1366192091.USD","LU1267930813.SGD","LU1712237335.SGD","LU0823434583.USD","LU2023250504.SGD","LU0432979614.USD","LU0320765059.SGD","IE00BVYPNV92.GBP","LU2552382058.USD","LU2471134796.USD","LU0795875169.SGD","SG9999001176.USD","IE0004445239.USD","BK4585","LU1989771016.USD","LU0912757837.SGD","ABBV","LU2112291526.USD","IE00BVYPNW00.USD","LU1127390331.HKD","LU1868837300.USD","LU1057294990.SGD","LU2505996509.AUD","LU1037948897.HKD","LU2324357040.USD","LU1778281490.HKD","LU0128525929.USD","LU2129689514.USD","CANC","IE00BN8TJ469.HKD","LU0057025933.USD","LU0994945656.USD","LU1064131342.USD","LU0133085943.USD","XLV","LU2125909247.SGD","LU0198837287.USD","LU1914381329.SGD","IE00BGHQF631.EUR","LU0792757196.USD","LU2746668461.USD","IE00BLSP4452.SGD","LU1571399168.USD","LU0965509283.SGD","LU1988902786.USD","LU0079474960.USD","LU1629891620.HKD","LU0094547139.USD","PJP","LU1868836914.USD","LU2756315664.SGD","ILDR","XBI","LU2462157665.USD","LU0234570918.USD","IE00BSNM7G36.USD","GB00BDT5M118.USD","LU1066051498.USD","PBE","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}